BioAge Labs, Inc. (BIOA)

BioAge Labs Statistics

Total Valuation

BioAge Labs has a market cap or net worth of $322.70 million. The enterprise value is $33.97 million.

Market Cap	322.70M
Enterprise Value	33.97M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

BioAge Labs has 35.86 million shares outstanding. The number of shares has increased by 1,576.12% in one year.

Current Share Class	35.86M
Shares Outstanding	35.86M
Shares Change (YoY)	+1,576.12%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.64%
Owned by Institutions (%)	42.91%
Float	22.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	54.59
Forward PS	46.35
PB Ratio	1.16
P/TBV Ratio	1.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.87, with a Debt / Equity ratio of 0.03.

Current Ratio	11.87
Quick Ratio	11.69
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-97.10

Financial Efficiency

Return on equity (ROE) is -25.64% and return on invested capital (ROIC) is -18.43%.

Return on Equity (ROE)	-25.64%
Return on Assets (ROA)	-17.46%
Return on Invested Capital (ROIC)	-18.43%
Return on Capital Employed (ROCE)	-31.97%
Revenue Per Employee	$92,453
Profits Per Employee	-$1.18M
Employee Count	64
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-52.98%
50-Day Moving Average	6.63
200-Day Moving Average	4.88
Relative Strength Index (RSI)	73.24
Average Volume (20 Days)	276,692

Short Selling Information

The latest short interest is 463,626, so 1.29% of the outstanding shares have been sold short.

Short Interest	463,626
Short Previous Month	692,983
Short % of Shares Out	1.29%
Short % of Float	2.07%
Short Ratio (days to cover)	0.84

Income Statement

In the last 12 months, BioAge Labs had revenue of $5.92 million and -$75.79 million in losses. Loss per share was -$2.11.

Revenue	5.92M
Gross Profit	-3.74M
Operating Income	-89.72M
Pretax Income	-75.79M
Net Income	-75.79M
EBITDA	-89.53M
EBIT	-89.72M
Loss Per Share	-$2.11

Balance Sheet

The company has $285.78 million in cash and $7.13 million in debt, giving a net cash position of $288.72 million or $8.05 per share.

Cash & Cash Equivalents	285.78M
Total Debt	7.13M
Net Cash	288.72M
Net Cash Per Share	$8.05
Equity (Book Value)	277.46M
Book Value Per Share	7.74
Working Capital	266.34M

Cash Flow

In the last 12 months, operating cash flow was -$58.51 million and capital expenditures -$633,000, giving a free cash flow of -$59.15 million.

Operating Cash Flow	-58.51M
Capital Expenditures	-633,000
Free Cash Flow	-59.15M
FCF Per Share	-$1.65

Margins

Gross Margin	-63.17%
Operating Margin	-1,516.29%
Pretax Margin	-1,280.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAge Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,576.12%
Shareholder Yield	-1,576.12%
Earnings Yield	-23.49%
FCF Yield	-18.33%

Analyst Forecast

Price Target	$9.00
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioAge Labs has an Altman Z-Score of 4.7 and a Piotroski F-Score of 1.

Altman Z-Score	4.7
Piotroski F-Score	1